BREMBILLA, GIORGIO
 Distribuzione geografica
Continente #
EU - Europa 272
NA - Nord America 221
AS - Asia 117
AF - Africa 6
OC - Oceania 3
SA - Sud America 1
Totale 620
Nazione #
US - Stati Uniti d'America 221
IT - Italia 141
CN - Cina 69
SE - Svezia 63
SG - Singapore 33
RU - Federazione Russa 29
IE - Irlanda 11
DE - Germania 8
FI - Finlandia 7
EG - Egitto 6
GB - Regno Unito 4
IN - India 4
AU - Australia 3
HK - Hong Kong 3
TW - Taiwan 3
BE - Belgio 2
BG - Bulgaria 2
FR - Francia 2
JP - Giappone 2
MY - Malesia 2
GR - Grecia 1
KR - Corea 1
NL - Olanda 1
PY - Paraguay 1
UA - Ucraina 1
Totale 620
Città #
Milan 45
New York 38
Shanghai 31
Ashburn 29
Singapore 21
Boardman 17
Lawrence 16
Princeton 16
Moscow 15
Rome 13
Dublin 11
Los Angeles 10
Suzhou 10
Turin 9
Washington 8
Helsinki 7
Damietta 6
Naples 5
Bolzano 4
Council Bluffs 4
Dallas 4
Padova 4
Bari 3
Paderborn 3
Acerra 2
Atrani 2
Bergamo 2
Bethesda 2
Bologna 2
Brooklyn 2
Brussels 2
Canberra 2
Caponago 2
Ceggia 2
Falconara Marittima 2
Guwahati 2
Hong Kong 2
Jiaxing 2
Kuala Lumpur 2
Palermo 2
Pune 2
Razgrad 2
Rochester 2
Seattle 2
Taipei 2
Vazzola 2
Vigonza 2
Aix-en-Provence 1
Asunción 1
Beijing 1
Bregnano 1
Brescia 1
Chicago 1
Essen 1
Fiorano Modenese 1
Freiburg im Breisgau 1
Giussano 1
Hangzhou 1
Kunming 1
Lewisham 1
London 1
Lucca 1
Macerata 1
Munich 1
Nerviano 1
Neyagawa 1
Pisa 1
Quanzhou 1
Romford 1
San Jose 1
Santa Clara 1
Segrate 1
Seoul 1
Shenzhen 1
Springfield 1
Stanghella 1
Sydney 1
Torrile 1
Treviso 1
Tuscania 1
Udine 1
Wuxi 1
Yiwu 1
Totale 411
Nome #
Simplification of prostate MRI protocol and development of a novel MRI technique for prostate cancer detection and characterization 100
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 39
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 33
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 31
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 27
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 27
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 25
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 24
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 24
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 24
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 19
Embolization of superior rectal arteries for transfusion dependent haemorrhoidal bleeding in severely cardiopathic patients: a new field of application of the “emborrhoid” technique 19
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 19
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 18
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 18
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 17
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 17
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness 17
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 16
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 15
MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer? 14
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection 14
US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer 14
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 13
Beyond diagnosis: is there a role for radiomics in prostate cancer management? 13
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI 12
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer 12
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 12
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-13 C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade 11
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 11
Tackling Interobserver Variability in Multiparametric Magnetic Resonance Imaging (MRI): Is MRI Even Better than We Think for Prostate Cancer Diagnosis? 11
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging 10
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 10
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 9
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 9
Therapeutic EUS: Biliary drainage - The interventional radiologist's perspective 8
Totale 712
Categoria #
all - tutte 7.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 1 0 0 0 1 0 0 0
2020/20214 0 0 0 0 1 2 0 0 0 0 1 0
2021/202212 0 4 1 2 0 1 3 1 0 0 0 0
2022/2023183 40 22 13 10 3 13 10 13 4 5 32 18
2023/2024363 6 22 36 33 28 76 10 30 5 40 31 46
2024/2025133 68 29 35 1 0 0 0 0 0 0 0 0
Totale 712